Batch checker
Check a Unicure India Ltd batch number
97 batches by Unicure India Ltd have been declared Not of Standard Quality in CDSCO or state-lab alerts. Type your batch number to check it, or scan the full list below. Full manufacturer record
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Olanzapine Tablets IP 5 mg | Batch EOCT1313Mfg Jul 2025 · Exp Jun 2027 | The sample does not conform to IP standards with respect to the test Assay.Assay | DTL, ThrissurState lab | Sep 2026 |
| Folic Acid Tablets IP 0.4 mg | Batch FO1TE011Mfg Oct 2024 · Exp Sep 2027 | The sample does not conform to IP standards. It fails the Descriptive part for tablets as per IP, as specified in the Laboratory Protocol.Other | DTL, TVPMState lab | Sep 2026 |
| Folic Acid Tablets IP 0.4 mg | Batch FO1TE058Mfg Nov 2024 · Exp Oct 2027 | The sample does not conform to IP standards. It fails the Descriptive part for tablets as per IP.Other | DTL, TVPMState lab | Sep 2026 |
| Folic Acid Tablets IP 0.4 mg | Batch FO1TE045Mfg Oct 2024 · Exp Sep 2027 | The sample does not conform to the IP standards with respect to Description.Description | DTL, ThrissurState lab | Sep 2026 |
| Folic Acid Tablets IP 0.4 mg | Batch FO1TE064Mfg Nov 2024 · Exp Oct 2027 | The sample does not conform to IP standards. It fails the 'Descriptive part' for tablets as per IP.Other | DTL, TVPMState lab | Sep 2026 |
| Folic Acid Tablets IP 0.4 mg | Batch FO1TE009Mfg Oct 2024 · Exp Sep 2027 | The sample does not conform to IP standards. It fails the 'Descriptive part' for tablets as per IP, as specified in the Laboratory Protocol.Other | DTL TVPMState lab | Sep 2026 |
| Folic Acid Tablets IP 0.4 mg | Batch FO1TE010Mfg Oct 2024 · Exp Sep 2027 | The sample does not conform to IP standards. It fails the 'Descriptive part' for tablets as per IP, as specified in the Laboratory Protocol.Other | DTL, TVPMState lab | Sep 2026 |
| Folic Acid Tablets IP 0.4 mg | Batch FO1TE050Mfg Oct 2024 · Exp Sep 2027 | The sample does not conform to IP standards. It fails the 'Descriptive part' for tablets as per IP, as specified in the Laboratory Protocol.Other | DTL, TVPMState lab | Sep 2026 |
| Folic Acid Tablets IP 0.4 mg | Batch FO1TE022Mfg Oct 2024 · Exp Sep 2027 | Sample does not conform to IP standards. This particular batch of sample fails in Descriptive part.Other | RDTL , ErnakulamState lab | Sep 2026 |
| Folic Acid Tablets IP 0.4 mg | Batch FO1TE067Mfg Nov 2024 · Exp Oct 2027 | The sample does not conform to IP standards. It fails the 'Descriptive part' for tablets as per IP.Other | DTL, TVPMState lab | Sep 2026 |
| Folic Acid Tablets IP 0.4 mg | Batch FO1TE026Mfg Oct 2024 · Exp Sep 2027 | The sample does not conform to IP standards. It fails the 'Descriptive part' for tablets as per IP.Other | DTL, TVPMState lab | Sep 2026 |
| Folic Acid Tablets IP 0.4 mg | Batch FO1TE016Mfg Oct 2024 · Exp Sep 2027 | The sample does not conform to IP standards. It fails the 'Descriptive part' for tablets as per IP, as specified in the Laboratory Protocol.Other | DTL, TVPMState lab | Sep 2026 |
| Folic Acid Tablets IP 0.4 mg | Batch FO1TE065Mfg Nov 2024 · Exp Oct 2027 | The sample does not conform to IP standards. If fails the tests'Assay' and 'Dissolution' as per IP, as specified in the Laboratory ProtocolAssay | DTL,TVPMState lab | Sep 2026 |
| Folic Acid Tablets IP 0.4 mg | Batch FO1TE023Mfg Oct 2024 · Exp Sep 2027 | The sample does not conform to the IP Standards with respect to DescriptionDescription | DTL, ThrissurState lab | Sep 2026 |
| Folic Acid Tablets IP 0.4 mg | Batch FO1TE035Mfg Oct 2024 · Exp Sep 2027 | The sample does not conform to the IP Standards with respect to DescriptionDescription | DTL, ThrissurState lab | Sep 2026 |
| Vildagliptin Tablets I.P. 50 mg | Batch VFGT1214Mfg Mar 2025 · Exp Feb 2027 | The sample does not conform to I.P with respect to the test for Assay of VildagliptinAssay | CDTL, IndoreCDSCO lab | Aug 2026 |
| Ibuprofen Tablets I.P 400mg | Batch IBBT1401Mfg Apr 2026 · Exp Mar 2028 | Dissolution Test: (Four out of Six units at stage I are less than Q-25% i.e less than 50%)Dissolution | SDTL, PunjabState lab | Aug 2026 |
| Folic Acid Tablets IP 0.4 mg | Batch F01TE055Mfg Oct 2024 · Exp Sep 2027 | The particular batch of sample fails in Descriptive part and tests Dissolution and Assay of Folic acidAssay | RDTL, EKMState lab | Aug 2026 |
| Azithromycin Oral Suspension IP 100mg/5ml | Batch AZS1401Mfg May 2026 · Exp Apr 2028 | The content of Azithromycin I.P. eq to Anhydrous Azithromycin found to be 80.34 mg per 5 ml (80.34%) against label claim of 100 mg per 5 mlLabelling | SDTL, PunjabState lab | Aug 2026 |
| Voglibose Tablets I.P 0.3mg | Batch VBT1408Mfg Apr 2026 · Exp Mar 2028 | MisbrandedMisbranded | Andmand NicobarState lab | Jun 2026 |
| Terbutaline Sulphate, Bromhexine Hydrochloride, Guaiphenesin & Menthol Syrup | Batch EM1LF005Mfg Apr 2025 · Exp Mar 2027 | ContentOther | DTL, Chennai-06State lab | Jun 2026 |
| Folic Acid Tablets IP 0.4 mg | Batch FO1TE063Mfg Nov 2024 · Exp Oct 2027 | Sample does not conform to IP standards. It fails the tests Dissolution and Assay as per IP.Assay | DTL, KonniState lab | Jun 2026 |
| Folic Acid Tablets IP. 0.4 mg | Batch FO1TE033Mfg Oct 2024 · Exp Sep 2027 | DescriptiveOther | RDTL ErnakulamState lab | May 2026 |
| Folic Acid Tablets IP. 0.4 mg | Batch FO1TE048Mfg Oct 2024 · Exp Sep 2027 | Description, Dissolution and AssayAssay | DTL ThrissurState lab | May 2026 |
| Atorvastatin Tablets IP 10mg | Batch AUVT1304Mfg Jul 2025 · Exp Jun 2027 | Does not conform to IP Standards with respect to the Dissolution TestDissolution | Government Analyst, Food & Drugs Admn. Bambolim, GoaState lab | May 2026 |
| Aspirin Gastro-resistant Tablets IP 75 mg | Batch ANET1273Mfg Oct 2024 · Exp Sep 2026 | Dissolution, Salicylic Acid and Assay as per IPAssay | DTL KonniState lab | May 2026 |
| Aspirin Gastro-resistant Tablets IP 75 mg | Batch ANET1283Mfg Oct 2024 · Exp Sep 2026 | Dissolution, Salicylic Acid and AssayAssay | DTL ThrissurState lab | May 2026 |
| Aspirin Gastro-Resistant Tablets IP 75mg | Batch ANET1243Mfg May 2024 · Exp Apr 2026 | The Sample fails the test 'Descriptive Part, Dissolution, Salicylic Acid and Assay as per IPAssay | DTL ThiruvananthapuramState lab | Apr 2026 |
| Lactulose Solution IP 10 gm/15ml | Batch LLS1337Mfg Aug 2025 · Exp Jul 2027 | The sample does not conform to IP with respect to test for Microbial contamination and Assay/content of LactuloseAssay | CDL, KolkataCDSCO lab | Mar 2026 |
| Lactulose Solution IP 10 gm/15ml | Batch LLS1311Mfg May 2025 · Exp Apr 2027 | The sample does not conform to IP with respect to test for Microbial contamination and Assay/content of LactuloseAssay | CDL, KolkataCDSCO lab | Mar 2026 |
| Paracetamol Tablets IP 500mg | Batch PCT1211Mfg Aug 2024 · Exp Jul 2026 | The sample does not confirm to IP2022 requirement withespect to Dissolution TestDissolution | DTL, Dalgate Srinagar Kashmir (J & K)State lab | Feb 2026 |
| Labetalol Tablets I.P 100mg | Batch LA1TE011Mfg Aug 2024 · Exp Jul 2026 | The sample does not conform to IP Standards with respect to the test Dissolution.Dissolution | DTL ThrissurState lab | Feb 2026 |
| Fenofibrate Capsules I.P (200 mg) | Batch FFC1201Mfg Jul 2024 · Exp Jun 2026 | Test for Uniformity of Weight and DissolutionDissolution | DTL, Bengaluru, KarnatakaState lab | Feb 2026 |
| Aspirin Gastro-resistant Tablets IP 75 mg. | Batch ANET1295Mfg Dec 2024 · Exp Nov 2026 | The sample does not conform to I.P.w.r.t. the tests for Dissolution in Acid Stage for Aspirin.Dissolution | RDTL, GuwahatiState lab | Feb 2026 |
| Aspirin Gastro Resistant Tablets IP 75mg | Batch ANET 1269Mfg Oct 2024 · Exp Sep 2026 | Sample fails the test Dissolution' as per IP as specified in the Laboratory ProtocolDissolution | DTL ThiruvananthapuramState lab | Feb 2026 |
| Terbutaline Sulphate, Bromhexine Hydrochloride, Guiaphenesin & Menthol Syrup | Batch EM1LF002Mfg Apr 2025 · Exp Mar 2027 | ContentOther | Drugs Testing Laboratory, Madurai-19State lab | Jan 2026 |
| Iron And Folic Acid Tablets I.P. | Batch IFAT1245Mfg Mar 2025 · Exp Feb 2027 | The sample does not conform to IP with respect to Description.Description | CDL, KolkataCDSCO lab | Jan 2026 |
| Ciprofloxacin Tablets I.P 500mg | Batch CCT1303Mfg Apr 2025 · Exp Mar 2027 | Test for Uniformity of WeightUniformity of weight/content | RDTL, Hubli, KarnatakaState lab | Jan 2026 |
| Hydroxyzine Oral Solution I.P. | Batch HO1LF002Mfg Jun 2025 · Exp May 2027 | The sample does not conform to claim as per IP 2022 in respect to The test of Related SubstanceRelated substances | CDL, KolkataCDSCO lab | Dec 2025 |
| Glipizide and Metformin Tablets USP | Batch URDT0328Mfg Jan 2023 · Exp Dec 2025 | The sample does not conform to the IP with respect to Dissolution of Glipizide.Dissolution | DTL UdaipurState lab | Dec 2025 |
| Amitriptyline Tablets IP 25 mg | Batch AMT1305Mfg May 2025 · Exp Apr 2027 | UniformityUniformity of weight/content | Drugs Testing Laboratory, Madurai-19State lab | Nov 2025 |
| Cloberasol Propionate and Salicylic Acid Ointment | Batch 1210CSOMfg Mar 2025 · Exp Feb 2027 | ContentOther | Drugs Testing Laboratory, Chennai-06State lab | Oct 2025 |
| Aspirin Gastro- resistant Tablets IP (150mg) | Batch URDT2771Mfg Nov 2023 · Exp Oct 2025 | Assay of AspirinAssay | KarnatakaState lab | Aug 2025 |
| Paracetamol Tablets IP (500mg) Jan Aushadhi | Batch PCT1208Mfg Aug 2024 · Exp Jul 2026 | Dissolution test of paracetamol.Dissolution | DTL Srinagar (J&K) & MDTL Kathua (J&K)State lab | Jun 2025 |
| Nitrofurantoin Tablets I.P 100 mg | Batch NFDT1201Mfg Oct 2024 · Exp Sep 2026 | DissolutionDissolution | CDTL IndoreCDSCO lab | Jun 2025 |
| Labetalol Tablets IP 100mg | Batch LA1TE012Mfg Aug 2024 · Exp Jul 2026 | Dissolution of Labetalol Hydrochloride TabletsDissolution | CDTL ChennaiCDSCO lab | Jun 2025 |
| Aspirin Gastro Resistant Tab IP 75 mg | Batch ANET1235Mfg May 2024 · Exp Apr 2026 | It fails the test ?Dissolution? Specified in the laboratory protocol as per IPDissolution | DTL ThiruvananthapuramState lab | Apr 2025 |
| Metoprolol Succinate Prolonged Release Tablets IP | Batch URDT0654Mfg Mar 2023 · Exp Feb 2025 | It fails the test ?Assay? as per IP standards [Amendment List - 05 to IP 2022]Assay | DTL ThiruvananthapuramState lab | Dec 2024 |
| Metoprolol Succinate Prolonged Release Tablets IP | Batch URDT0653Mfg Mar 2023 · Exp Feb 2025 | It fails the test ?Assay? as per IP standards [Amendment List - 05 to IP 2022]Assay | DTL ThiruvananthapuramState lab | Dec 2024 |
| Metoprolol Succinate Prolonged Release Tablets IP | Batch URDT0652Mfg Mar 2023 · Exp Feb 2025 | It fails the test ?Assay? as per IP standards [Amendment List - 05 to IP 2022]Assay | DTL ThiruvananthapuramState lab | Dec 2024 |
| Aspirin Gastro- resistant Tablets IP 75mg | Batch ANET1121Mfg Aug 2023 · Exp Jul 2025 | Test of Dissolution Buffer StageDissolution | CDL KolkataCDSCO lab | Dec 2024 |
| Terbutaline Sulphate, Ambroxol Hydrochloride and Guaiphenesin syrup | Batch TM1LE027Mfg Apr 2024 · Exp Mar 2026 | The sample fails descriptive part for liquid oral dosage forms as per schedule V of Drugs & Cosmetics Act and Rules. The syrup contains red coloured sedimented particlesDescription | DTL ThiruvananthapuramState lab | Nov 2024 |
| Paracetamol Tablets I.P. 500mg | Batch PCT1212Mfg Aug 2024 · Exp Jul 2026 | DissolutionDissolution | SDTL Agartala, TripuraState lab | Nov 2024 |
| Aspirin Gastro- resistant Tablets IP 75 mg | Batch ANET1107Mfg Jul 2023 · Exp Dec 2024 | Test for Salicylic AcidOther | CDL KolkataCDSCO lab | Nov 2024 |
| Aspirin Gastro Resistant Tab IP | Batch URDT2785Mfg Nov 2023 · Exp Oct 2025 | It fails the test ?Dissolution? Specified in the Laboratory Protocol as per IPDissolution | DTL ThiruvananthapuramState lab | Nov 2024 |
| Paracetamol Tablets IP 650 mg [Nopain-650] | Batch URDT2433Mfg Oct 2023 · Exp Sep 2026 | It fails the test ?Dissolution? Specified in the Laboratory Protocol as per IPDissolution | DTL ThiruvananthapuramState lab | Oct 2024 |
| Calcium and Vitamin D3 Tablets I.P. | Batch UDT11151Mfg Aug 2023 · Exp Jan 2025 | Assay of vitamin D3Assay | RDTL GuwahatiCDSCO lab | Aug 2024 |
| Sodium Valporate Gastro Resistant Tablets IP 200 mg | Batch SVT1140Mfg Sep 2023 · Exp Aug 2026 | It fails the test ?Dissolution? as per IPDissolution | DTL ThiruvananthapuramState lab | Jul 2024 |
| Etamsylat Tablets 500 mg | Batch ELT1104Mfg Feb 2024 · Exp Jul 2024 | DescriptionDescription | CDTL MumbaiCDSCO lab | Jun 2024 |
| Sodium Valproate Gastro-resistant Tablets IP 200 mg | Batch SVT1136Mfg Jul 2023 · Exp Dec 2024 | Dissolution in ACID stageDissolution | CDTL MumbaiCDSCO lab | Mar 2024 |
| Diacerein Tablets 50 mg | Batch DCT1102Mfg Oct 2023 · Exp Sep 2025 | DescriptionDescription | CDTL MumbaiCDSCO lab | Mar 2024 |
| Calcium and Vitamin D3 Tablets I.P. | Batch UDT10723Mfg Mar 2023 · Exp Aug 2024 | DescriptionDescription | RDTL GuwahatiState lab | Mar 2024 |
| Oseltamivir Oral Suspension I.P. 12 mg | Batch URDP1153Mfg May 2023 · Exp Oct 2024 | DescriptionDescription | CDL KolkataCDSCO lab | Feb 2024 |
| Ondansetron Tablets IP 4 mg | Batch SMT1006Mfg Nov 2022 · Exp Oct 2024 | DissolutionDissolution | RDTL GuwahatiState lab | Jan 2024 |
| Calcium and Vitamin D3 Tablets I.P | Batch UDT10704Mfg Mar 2023 · Exp Aug 2024 | DescriptionDescription | RDTL GuwahatiState lab | Jan 2024 |
| Piroxicam Tablets I.P. 20 mg, | Batch URDT2340Mfg Oct 2023 · Exp Sep 2026 | DissolutionDissolution | CDL KolkataCDSCO lab | Dec 2023 |
| CALCIUM AND VITAMIN D3 TABLETS I.P. | Batch UDT10673Mfg Feb 2023 · Exp Jul 2024 | DescriptionDescription | RDTL GuwahatiState lab | Dec 2023 |
| Montelukast Sodium and Levocetirizine Hydrochloride Tablets I.P. | Batch MLCT1026Mfg Feb 2023 · Exp Jan 2025 | DissolutionDissolution | CDL KolkataCDSCO lab | Nov 2023 |
| Ramipril Tablets I.P. 5 mg. | Batch RMFT1001Mfg Jun 2022 · Exp May 2024 | content of Ramipril (Assay)Assay | RDTL GuwahatiState lab | Oct 2023 |
| Lorazepam Tablets I.P. 2 mg | Batch LZMT100 6Mfg Feb 2023 · Exp Jan 2025 | Dissolution and AssayAssay | CDTL MumbaiCDSCO lab | Aug 2023 |
| Prednisolone Tablets I.P. 5 mg | Batch PDT1009Mfg Oct 2022 · Exp Sep 2024 | Related SubstancesRelated substances | CDL KolkataCDSCO lab | Jun 2023 |
| CLOZAPINE TABLETS I.P. 100 MG | Batch CZPT1006Mfg Nov 2022 · Exp Apr 2024 | AssayAssay | CDTL HyderabadCDSCO lab | Jun 2023 |
| Zinc Sulphate Dispersible Tablets IP 20 mg | Batch ZST922Mfg Feb 2022 · Exp Jan 2024 | AssayAssay | CDTL ChennaiCDSCO lab | Feb 2023 |
| Zinc Sulphate Dispersible Tablets IP 20 mg | Batch ZST903Mfg Jan 2022 · Exp Dec 2023 | AssayAssay | CDTL ChennaiCDSCO lab | Dec 2022 |
| Zinc Sulphate Dispersible Tablets IP 20 mg | Batch ZST922Mfg Feb 2022 · Exp Jan 2024 | AssayAssay | CDTL ChennaiCDSCO lab | Nov 2022 |
| Ramipril Tablets IP 5.0 mg | Batch RMFT905Mfg Oct 2021 · Exp Sep 2023 | Assay of RamiprilAssay | RDTL ChandigarhCDSCO lab | Nov 2022 |
| PRE AND PROBIOTIC CAPSULES | Batch SL1CB016Mfg Nov 2021 · Exp Apr 2023 | Identification and Assay of Streptococcus faecalisAssay | RDTL ChandigarhCDSCO lab | Jun 2022 |
| Methylcobalamin Tablets 500 mcg | Batch MBT 904Mfg May 2021 · Exp Apr 2023 | AssayAssay | CDL KolkataCDSCO lab | Mar 2022 |
| Finasteride Tablets I.P. 5 mg | Batch FNST901Mfg Jun 2021 · Exp May 2023 | DissolutionDissolution | CDL KolkataCDSCO lab | Mar 2022 |
| Aspirin Gastro- resistant Tablets I.P. 150 mg | Batch APET901Mfg May 2021 · Exp Apr 2023 | Salicylic AcidOther | CDTL MumbaiCDSCO lab | Mar 2022 |
| Vitamin B ? Complex Tablets NFI III | Batch VPT801Mfg Jun 2020 · Exp Nov 2021 | Description, Assay of Vitamin B1 & Calcium PantothenateAssay | CDL KolkataCDSCO lab | Nov 2021 |
| NORFLOXACIN TABLETS IP 400 MG | Batch NT802Mfg Oct 2020 · Exp Sep 2022 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | Oct 2021 |
| Atorvastatin Tablets I.P. 20 mg. | Batch AVBT806Mfg Oct 2020 · Exp Sep 2022 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Aug 2021 |
| Sodium Valproate Gastro Resistant Tablets IP 200 mg | Batch SVT871Mfg Dec 2020 · Exp May 2022 | Related SubstancesRelated substances | CDL KolkataCDSCO lab | Jul 2021 |
| Atorvastatin Tablets IP 20 mg | Batch AVBT802Mfg Jul 2020 · Exp Jun 2022 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Jun 2021 |
| Alusil (Aluminium, Magnesium and Simethicone Chewable Tablets I.P.) | Batch ACT801Mfg Aug 2020 · Exp Jul 2022 | Assay of Polydimethyl-siloxane (Simethicone)Assay | CDL KolkataCDSCO lab | Jun 2021 |
| Nofloxacin Tablets I.P. 400 mg | Batch NT801Mfg Jul 2020 · Exp Jun 2022 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | May 2021 |
| Aspirin Gastro-Resistant Tablets IP 150 mg | Batch APET716Mfg Jun 2019 · Exp May 2021 | Test for Salicylic AcidOther | CDTL MumbaiCDSCO lab | Feb 2021 |
| SULFASALAZINE TABLETS B.P. 500 mg | Batch SSZT718Mfg Mar 2020 · Exp Feb 2022 | Related SubstancesRelated substances | RDTL ChandigarhCDSCO lab | Dec 2020 |
| Ondansetron Tablets I.P. 8 mg | Batch SMAT 703Mfg Nov 2019 · Exp Oct 2021 | DescriptionDescription | CDL KolkataCDSCO lab | Oct 2020 |
| Telmisartan Tablets I.P. 20 mg | Batch TLMT703Mfg Jul 2019 · Exp Jun 2021 | DissolutionDissolution | CDL KolkataCDSCO lab | Jun 2020 |
| Setnorm ? 4 (Ondansetron Tablets IP 4 mg) | Batch SMT610ZMfg Feb 2019 · Exp Jan 2021 | DescriptionDescription | CDL KolkataCDSCO lab | Jun 2020 |
| Tranexamic Acid Tablets I.P. 500mg | Batch TAT607Mfg Oct 2018 · Exp Sep 2020 | DisintegrationDisintegration | RDTL GuwahatiCDSCO lab | Apr 2020 |
| Thyrocure-50 (Thyroxine Tablets I.P. 50 mcg) | Batch THAT616Mfg Dec 2018 · Exp May 2020 | AssayAssay | CDL KolkataCDSCO lab | Sep 2019 |
| Thyrocure-100 (Thyroxine Tablets I.P. 100 mcg) | Batch THDT611Mfg Dec 2018 · Exp May 2020 | AssayAssay | CDL KolkataCDSCO lab | Aug 2019 |
| Thyrocure - 100 (Thyroxine Tablets I.P. 100 mcg) | Batch THDT605Mfg Jul 2018 · Exp Dec 2019 | AssayAssay | CDL KolkataCDSCO lab | Apr 2019 |
| PANTOPRAZOLE GASTRO- RESISTANT TABLETS IP 40 MG | Batch TJPE802Mfg Mar 2018 · Exp Feb 2020 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | Apr 2019 |
Data: CDSCO NSQ portal, Jan 2019 to Sep 2026. Absence from the list is not proof of quality.